Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00056589
Status:
COMPLETED
Last Update Posted:
2017-01-11
First Post:
2003-03-18
Brief Title:
Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03
Start Date Type:
None
Primary Completion Date:
2003-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-10
Completion Date Type:
ACTUAL
First Submit Date:
2003-03-18
First Submit QC Date:
March 19 2003
Study First Post Date:
2003-03-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-10
Last Update Post Date:
2017-01-11
Last Update Post Date Type:
ESTIMATED